Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00049985
NCT00049985
View on ClinicalTrials.gov
Heart Failure and Anemia
PHASE2
Completed
INTERVENTIONAL
Enrollment
300
Participants
Timeline
Start Date
July 31, 2002
Conditions
Heart Failure
Anemia
Interventions
DRUG
Darbepoetin Alfa
Sponsors
Lead Sponsor
Amgen
All Listed Sponsors
lead
Amgen
INDUSTRY
NCT00049985 - Heart Failure and Anemia | Biotech Hunter | Biotech Hunter